Tom has helped U.S. and international businesses, issuers, and investment banks negotiate and close billions of dollars in cross-border financings, which includes multiple deals recognized as the "Deal of the Year" in their respective industries. For Tom, teamwork is the essential ingredient for success in complex deals.
Located in:
Areas of Focus:
Tom is an exceptionally experienced attorney who concentrates his practice on U.S. cross-border securities and corporate law matters. With a particular focus on U.S.-Canada activity, every year he and his team advise clients with respect to financing transactions totaling billions of dollars – regularly landing them among the top performers on Thomson Reuters' annual league tables and recently earning the "Pharmaceutical Deal of the Year" Atlas Award from Global M&A Network.
Tom's services adapt and grow along with the needs of his clients. He represents U.S. and foreign issuers and investment banks in a broad range of public and private financings, including financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS), other cross-border public offerings, and U.S.-foreign private placements (including Rule 144A, Regulation D, and Regulation S offerings). Tom also advises U.S. and foreign issuers with respect to the U.S. securities and corporate law aspects of mergers and acquisition transactions, including portfolio company roll-ups, as well as in connection with litigation arising from such deals.
Tom counsels U.S. and foreign issuers in connection with initial listings on the New York Stock Exchange (NYSE), the NYSE MKT, and the Nasdaq Stock Market (NASDAQ). He also helps clients ensure compliance with ongoing U.S. reporting and corporate governance requirements under U.S. federal securities laws and exchange rules, and acts as a principal American liaison (PAL) on the over-the-counter (OTC) international markets.
Tom has provided U.S. corporate and securities law advice for the following recent representative transactions/matters:
Life Sciences
Technology
Energy and Renewables
Mining
Underwriter/Agent Representations
Tom regularly acts for underwriters and agents on public and private offerings, including the following:
League Tables
Refinitiv's Global Capital Markets Review - Full Year 2022
Canada Equity & Equity-Related (CAL4) Manager Legal Advisor
Canada Equity & Equity-Related (CAL4) Issuer Legal Advisor
Global Equity & Equity-Related (G08) Issuer Legal Advisor
U.S. Equity and Equity-Related (AB2) Issuer Legal Advisor
U.S. Debt, Equity & Equity Related (AB1) Issuer Legal Advisor
U.S. Straight Debt Excluding ABS & MBS (AB7) Manager Legal Advisor
U.S. Straight Debt Including ABS & MBS (AB6) Issuer Legal Advisor
U.S. Straight Debt Excluding ABS & MBS (AB7) Issuer Legal Advisor
Bloomberg Global Legal Adviser
Canada Equity Offerings: Legal Adviser – Issuer Ranked by Deal Count
Canada Equity & Equity Linked: Legal Adviser – Issuer Ranked by Deal Count
Canada Equity, Equity Linked & Preferred: Legal Adviser – Issuer Ranked by Deal Count
Global Equity, Equity Linked & Rights: Legal Adviser – Issuer Ranked by Deal Count
U.S. Equity Offerings: Legal Adviser – Issuer Ranked by Deal Count
Representative matters may include engagements before joining Troutman Pepper.
Tom is a frequent speaker on U.S. corporate and securities laws matters. His recent speaking engagements include, but are not limited to, the following:
Firm News
05.04.23
Troutman Pepper's Capital Markets Practice Notches Top 2023 Q1 League Table Rankings
Sponsored Events
04.25.23
2023 Bloom Burton & Co. Healthcare Investor Conference
Sponsored Events
03.12.23
The 35th Annual ROTH Conference
Firm News
02.01.23
Troutman Pepper's Canadian Practice Tops League Tables for U.S. Law Firms for 9th Year in a Row
Articles + Publications
01.25.23
After JPM, What Are the Legal Dealmaking Trends to Watch?
Firm News
11.16.22
Troutman Pepper’s Capital Markets Practice Cements Strong Industry League Table Rankings Through Q3 2022